secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2025-06-16T23:59:59+00:00
Accession:  0000950170-25-086758
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharmaceuticals elects three directors and ratifies EY as auditor at 2025 annual meeting
--------------------------------------------------------------------------------

- Robert Azelby elected with 56.4M votes for, 3.2M withheld.
- Hongbo Lu elected with 52.0M votes for, 7.6M withheld.
- Heather Turner elected with 58.3M votes for, 1.3M withheld.
- Ratification of Ernst & Young as independent auditor for FY2025 passed with 64.8M for, 28.5K against.
- No broker non-votes on ratification; two proposals considered at June 11, 2025 meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017025086758/0000950170-25-086758-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017025086758/tern-20250611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-086758

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer